Keyphrases
Combination Therapy
100%
SERCA2a
100%
Pulmonary Arterial Hypertension
100%
Ca2+-ATPase
100%
Bone Morphogenetic protein-2 (BMP-2)
100%
Endoplasmic Reticulum Ca2+
100%
BMPR2
100%
Signal Transducer and Activator of Transcription 3
83%
AAV1
66%
Pulmonary Artery Smooth muscle Cells (PASMCs)
50%
Right Ventricular Function
33%
Therapeutic Potential
33%
Pulmonary Artery
33%
Monocrotaline
33%
Signal Transducer and Activator of Transcription 3 Inhibitor
33%
Small Interfering RNA (siRNA)
16%
Arterial Wall
16%
Right Ventricular Ejection Fraction
16%
Right Ventricular
16%
Endothelial Cells
16%
Transcription Factor
16%
Adenovirus
16%
Overexpressing
16%
Beneficial Effects
16%
Cell-to-cell
16%
Cardiac Magnetic Resonance Imaging (cMRI)
16%
Gene Transfer
16%
Decreased Expression
16%
Structural Change
16%
Transcriptome Analysis
16%
Functional Change
16%
Lung Disease
16%
Combined Therapy
16%
Vascular Remodeling
16%
Mean Pulmonary Artery Pressure (mPAP)
16%
Functional Alterations
16%
Model Validation
16%
Structural Alterations
16%
Cardiac Remodeling
16%
Pneumonectomy
16%
Single Therapy
16%
Vascular Resistance
16%
Lung Specimen
16%
Pharma
16%
Hypertension Patients
16%
Right Ventricular Systolic Pressure
16%
Severe Pulmonary Arterial Hypertension
16%
Efficient Model
16%
Intratracheal Delivery
16%
Left Pneumonectomy
16%
Wall Remodeling
16%
Virus Technology
16%
Medicine and Dentistry
Combination Therapy
100%
Pulmonary Hypertension
100%
STAT3 Protein
100%
Endoplasmic reticulum
75%
Adenosine Triphosphatase (Calcium)
75%
Bone Morphogenetic Protein Receptor 2
75%
Pneumonectomy
25%
Pulmonary Artery
25%
Systolic Blood Pressure
12%
Ejection Fraction
12%
Right Ventricular Function
12%
Transcription Factors
12%
Gene Expression Profiling
12%
Obstruction
12%
Endothelial Cell
12%
Heart Right Ventricle Failure
12%
Cardiac Magnetic Resonance Imaging
12%
Silo-Filler's Disease
12%
Downregulation
12%
Combined Therapy
12%
Vascular Resistance
12%
Vascular Remodeling
12%
Lung Artery Pressure
12%
Heart Ventricle Remodeling
12%
Adeno-Associated Virus
12%
Gene Transfer
12%
Small Interfering RNA
12%
Artery Wall
12%
Pulmonary Artery Smooth Muscle Cell
12%
Monocrotaline-Induced Pulmonary Hypertension
12%
Monocrotaline
12%
Lung
12%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Pulmonary Hypertension
100%
STAT3 Protein
100%
Adenosine Triphosphatase (Calcium)
75%
Bone Morphogenetic Protein Receptor 2
75%
Small Interfering RNA
12%
Obstruction
12%
Lung Disease
12%
Transcription Factors
12%
Transcriptome
12%
Adeno Associated Virus
12%
Gene Delivery
12%
Heart Ventricle Remodeling
12%
Heart Right Ventricle Failure
12%
Vascular Remodeling
12%
Monocrotaline-Induced Pulmonary Hypertension
12%
Monocrotaline
12%
Biochemistry, Genetics and Molecular Biology
STAT3
100%
ATPase
85%
Bone Morphogenetic Protein Receptor Type 2
85%
Magnetism
14%
Small Interfering RNA
14%
Transcription Factors
14%
Downregulation
14%
Gene Expression Profiling
14%
Adeno Associated Virus
14%
Vascular Resistance
14%
Systolic Blood Pressure
14%
Heart Ejection Fraction
14%
Lung Artery Pressure
14%
Heart Right Ventricle Function
14%